ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,537, issued on Jan. 27, was assigned to CRYSTAL BIOSCIENCE INC. (Emeryville, Calif.).
"Anti-CD38 antibody and methods of use thereof" was invented by Shelley Izquierdo (Berkeley, Calif.), Ellen Collarini (Oakland, Calif.), Christel Iffland (Arlington, Mass.) and William Don Harriman (Alameda, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies that specifically bind to CD38. The antibodies find use in a variety of treatment, diagnostic, and monitoring applications, which are also described. The present disclosure provides antibodies that specifically bind to, and in some embodiments, inhibit CD38. A subje...